Lycopene

1. What conditions has Lycopene been studied for?

• Cardiovascular outcomes: atherosclerosis-related processes (serum lipids, endothelial dysfunction, inflammation, blood pressure), coronary artery disease (CAD), hypertension, cardiovascular disease (CVD), stroke, coronary heart disease mortality, cerebrovascular disease mortality.

• Cancers: prostate cancer (most frequently highlighted), gastric cancer; broader “cancer” prevention/treatment is discussed in multiple reviews.

• Metabolic conditions: diabetes mellitus and metabolic syndrome.

• Male reproductive health: male infertility; phthalate (DEHP/MEHP)-associated male reproductive toxicity (preclinical).

• Neurologic/CNS disorders (mostly preclinical): Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, cerebral ischemia, epilepsy, depression; cognitive impairment models; neurotoxicant exposures (e.g., methylmercury, cadmium, MSG, TMT, t-BHP).

• Inflammation/oxidative-stress related disorders (broad): chronic inflammatory conditions and oxidative stress-mediated dysfunction; ulcerative colitis; liver/hepatic disorders; skin and bone diseases (mentioned in broad reviews).

• Other: heart failure (mentioned as an area of study in a review).

2. Does it work in treating those conditions? Summarize the evidence.

The studies collectively suggest potential benefit, but the strength of evidence varies substantially by outcome and is often limited by study design (many reviews, fewer clinical trials). The strongest human-level summary in the studies reviewed here is an umbrella review reporting mostly low-certainty evidence.

• Human evidence (umbrella review of meta-analyses/systematic reviews): One umbrella review found inverse associations between:

  • Tomato intake and all-cause mortality, coronary heart disease mortality, cerebrovascular disease mortality, prostate cancer, and gastric cancer.

  • Dietary lycopene intake or serum lycopene and all-cause mortality, prostate cancer, stroke, cardiovascular disease, metabolic syndrome, and male infertility.

  • Certainty: the same umbrella review reported that the “vast majority” of evidence was low or very low quality by GRADE, with only a minority rated moderate. This supports possible benefit but limits confidence in causality and effect size.

• Cardiovascular risk factors (mechanistic/clinical mix): Multiple reviews state lycopene may positively influence stages of atherosclerosis and affect serum lipids, endothelial dysfunction, inflammation, blood pressure, and antioxidative potential. However, at least one cardiovascular-focused review notes controversy and that mechanisms may explain contradictions, implying inconsistent findings across studies.

• Prostate cancer: Reviews describe anti-proliferative, cell-cycle arrest, and pro-apoptotic effects in vitro/in vivo models, and one review claims clinical studies provide a “clear image” for continuous adjunctive use, especially for prostate cancer. However, the umbrella review frames the overall human evidence quality as mostly low/very low, so clinical effectiveness remains uncertain based on these studies alone.

• Male infertility (preclinical toxicant model): An in vivo/in vitro study in a phthalate-toxicity model reported lycopene reversed DEHP/MEHP-associated changes (e.g., testosterone biosynthesis reduction, Sertoli cell secretory dysfunction, mitochondrial/oxidative damage) and implicated restoration of testosterone/androgen receptor (T/AR) signaling. This is supportive for mechanism and plausibility, but it is not direct evidence of benefit in typical human infertility.

• Neurologic disorders: A CNS-focused review describes broad neuroprotective effects and improved cognition/memory in rodent models, with proposed pathways (e.g., reduced oxidative stress/neuroinflammation, mitochondrial restoration; NF-κB/JNK inhibition; Nrf2/BDNF activation). These are largely preclinical findings and cannot establish clinical efficacy.

3. What health benefits does it have?

• Antioxidant effects: Lycopene is repeatedly described as a potent lipophilic antioxidant (including being characterized as very high among carotenoids), with the ability to interact with reactive oxygen species (ROS) and help prevent oxidative stress-related complications.

• Cardiovascular support (potential): Reviews describe potential benefits relevant to atherosclerosis and vascular health, including effects on:

  • Blood pressure (one review proposes ACE inhibition and regulation of nitric oxide bioavailability as mechanisms).

  • Lipids (proposed lowering LDL and improving HDL in a review context).

  • Endothelial function and inflammation (discussed as targets affected by lycopene).

• Potential reduction in risk of certain outcomes (associational human evidence): The umbrella review reports inverse associations between tomato/lycopene exposure and all-cause mortality, cardiovascular outcomes (including stroke/CVD), and certain cancers (notably prostate and gastric cancer).

• Male reproductive support (potential): The umbrella review reports an inverse association between dietary/serum lycopene and male infertility, and a mechanistic preclinical study suggests protection against phthalate-induced reproductive toxicity via T/AR signaling and mitigation of oxidative/mitochondrial damage.

• Anti-inflammatory/pleiotropic effects (proposed): Several reviews emphasize anti-inflammatory and broader “pleiotropic” actions (anti-proliferative, anti-atherogenic, etc.), but note that much of the supporting evidence is experimental rather than clinical.

4. Does it have any downsides or side effects?

• Overall safety: Multiple reviews state toxicity is uncommon and lycopene/carotenoids are generally considered safe at different doses. The umbrella review similarly concludes tomato/lycopene intake was “generally safe.”

• Allergy and contamination concerns: The umbrella review specifically notes caution is warranted for potential allergy and pollution (contaminants) related to tomato/lycopene exposure.

• Evidence limitations as a “downside” for decision-making: Several studies emphasize that clinical evidence is scarcer and less certain than experimental evidence, and the umbrella review rates most outcomes as low/very low certainty. This increases the risk of overestimating benefits.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report specific pharmacogenomic findings (i.e., no named genetic variants that predict better response, higher risk, or different dosing needs for lycopene).

• What can be inferred from these studies: Lycopene’s proposed mechanisms (e.g., antioxidant pathways; inflammatory signaling such as NF-κB/JNK; activation of Nrf2/BDNF; and in one model, testosterone/androgen receptor signaling) suggest plausible gene–nutrient interactions, but no variant-specific evidence is presented here.

• Practical implication: Based on these studies alone, there is insufficient evidence to recommend lycopene differently for specific genotypes.

References

1. Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders.
   Muhammad Imran, Fereshteh Ghorat, Iahtisham Ul-Haq, Habib Ur-Rehman, Farhan Aslam, Mojtaba Heydari, Mohammad Ali Shariati, Eleonora Okuskhanova, Zhanibek Yessimbekov, Muthu Thiruvengadam, Mohammad Hashem Hashempur, Maksim Rebezov (2020) - Antioxidants (Basel, Switzerland)
2. Nutritional Benefits of Lycopene and Beta-Carotene: A Comprehensive Overview.
   Tabussam Tufail, Huma Bader Ul Ain, Sana Noreen, Ali Ikram, Muhammad Tayyab Arshad, Muhammed Adem Abdullahi (2024) - Food science & nutrition
3. Lycopene: Food Sources, Biological Activities, and Human Health Benefits.
   Usman Mir Khan, Mustafa Sevindik, Ali Zarrabi, Mohammad Nami, Betul Ozdemir, Dilara Nur Kaplan, Zeliha Selamoglu, Muzaffar Hasan, Manoj Kumar, Mohammed M Alshehri, Javad Sharifi-Rad (2021) - Oxidative medicine and cellular longevity
4. Tomato and lycopene and multiple health outcomes: Umbrella review.
   Ni Li, Xiaoting Wu, Wen Zhuang, Lin Xia, Yi Chen, Chuncheng Wu, Zhiyong Rao, Liang Du, Rui Zhao, Mengshi Yi, Qianyi Wan, Yong Zhou (2021) - Food chemistry
5. Phthalate-induced testosterone/androgen receptor pathway disorder on spermatogenesis and antagonism of lycopene.
   Yi Zhao, Xue-Nan Li, Hao Zhang, Jia-Gen Cui, Jia-Xin Wang, Ming-Shan Chen, Jin-Long Li (2022) - Journal of hazardous materials
6. Lycopene: A Potent Antioxidant with Multiple Health Benefits.
   Mercy Omoye Shafe, Nontobeko Myllet Gumede, Trevor Tapiwa Nyakudya, Eliton Chivandi (2024) - Journal of nutrition and metabolism
7. Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases.
   May Nasser Bin-Jumah, Muhammad Shahid Nadeem, Sadaf Jamal Gilani, Bismillah Mubeen, Inam Ullah, Sami I Alzarea, Mohammed M Ghoneim, Sultan Alshehri, Fahad A Al-Abbasi, Imran Kazmi (2022) - Antioxidants (Basel, Switzerland)
8. Lycopene in the Prevention of Cardiovascular Diseases.
   Sylwia Przybylska, Grzegorz Tokarczyk (2022) - International journal of molecular sciences
9. The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene.
   Anna Kulawik, Judyta Cielecka-Piontek, Przemysław Zalewski (2023) - Nutrients
10. Bioactivities of phytochemicals present in tomato.
    Poonam Chaudhary, Ashita Sharma, Balwinder Singh, Avinash Kaur Nagpal (2018) - Journal of food science and technology
11. A review for the pharmacological effect of lycopene in central nervous system disorders.
    Dongjian Chen, Chao Huang, Zhuo Chen (2019) - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
12. Potential inhibitory effect of lycopene on prostate cancer.
    Mahdi Mirahmadi, Shayan Azimi-Hashemi, Ehsan Saburi, Hossein Kamali, Mandana Pishbin, Farzin Hadizadeh (2020) - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
13. Lycopene: A Critical Review of Digestion, Absorption, Metabolism, and Excretion.
    Joseph Arballo, Jaume Amengual, John W Erdman (2021) - Antioxidants (Basel, Switzerland)
14. Lycopene in protection against obesity and diabetes: A mechanistic review.
    Ruyuan Zhu, Beibei Chen, Ying Bai, Tianyi Miao, Li Rui, Hao Zhang, Bingke Xia, Yu Li, Sihua Gao, Xiang-Dong Wang, Dongwei Zhang (2020) - Pharmacological research
15. Let food be your medicine: nutraceutical properties of lycopene.
    Małgorzata Grabowska, Dariusz Wawrzyniak, Katarzyna Rolle, Piotr Chomczyński, Stefan Oziewicz, Stefan Jurga, Jan Barciszewski (2019) - Food & function
16. Lycopene and Vascular Health.
    Ioana Mozos, Dana Stoian, Alexandru Caraba, Clemens Malainer, Jarosław O Horbańczuk, Atanas G Atanasov (2018) - Frontiers in pharmacology
17. The Anti-Cancer Activity of Lycopene: A Systematic Review of Human and Animal Studies.
    Aleksandra Kapała, Małgorzata Szlendak, Emilia Motacka (2022) - Nutrients
18. Lycopene intake and the risk of erectile dysfunction in US adults: NHANES 2001-2004.
    Yue Gao, Chunhui Liu, Xun Lu, Kai Lu, Lei Zhang, Weipu Mao, Kehao Pan, Zichun Liang, Chao Sun, Ming Chen (2024) - Andrology
19. Can lycopene be considered an effective protection against cardiovascular disease?
    J Costa-Rodrigues, O Pinho, P R R Monteiro (2018) - Food chemistry

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.